CA2547947A1 - Azole derivatives as active superoxide radical inhibitors - Google Patents

Azole derivatives as active superoxide radical inhibitors Download PDF

Info

Publication number
CA2547947A1
CA2547947A1 CA002547947A CA2547947A CA2547947A1 CA 2547947 A1 CA2547947 A1 CA 2547947A1 CA 002547947 A CA002547947 A CA 002547947A CA 2547947 A CA2547947 A CA 2547947A CA 2547947 A1 CA2547947 A1 CA 2547947A1
Authority
CA
Canada
Prior art keywords
superoxide radical
phenyl
azole derivatives
radical inhibitors
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002547947A
Other languages
French (fr)
Other versions
CA2547947C (en
Inventor
Masatoshi Chihiro
Michiaki Tominaga
Yoichi Yabuuchi
Hajime Komatsu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Masatoshi Chihiro
Michiaki Tominaga
Yoichi Yabuuchi
Hajime Komatsu
Otsuka Pharmaceutical Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Masatoshi Chihiro, Michiaki Tominaga, Yoichi Yabuuchi, Hajime Komatsu, Otsuka Pharmaceutical Co., Ltd. filed Critical Masatoshi Chihiro
Publication of CA2547947A1 publication Critical patent/CA2547947A1/en
Application granted granted Critical
Publication of CA2547947C publication Critical patent/CA2547947C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/24—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6536—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and sulfur atoms with or without oxygen atoms, as the only ring hetero atoms
    • C07F9/6539—Five-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings

Abstract

Disclosed is an azole derivative represented by the general formula (1):

(see formula 1) [wherein R1 is phenyl which may have 1-3 lower alkoxy substituents, phenyl having a lower alkylenedioxy substituent or the like; R2 is hydrogen, phenyl, halogen, lower alkoxycarbonyl, lower alkyl, amino-lower alkyl which may have lower substituent, dihydrocarbostyril or the like;
R3 is a group of the formula:

(see formula 2) (in which R4B is hydroxyl, carboxyl, lower alkenyl or lower alkyl, m is 0, 1 or 2); X is S or O] or a salt thereof, useful as a superoxide radical inhibitor.
CA002547947A 1990-11-30 1991-11-29 Azole derivatives as active superoxide radical inhibitors Expired - Lifetime CA2547947C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP33772790 1990-11-30
JP2-337727 1990-11-30
CA002396738A CA2396738C (en) 1990-11-30 1991-11-29 Thiazole derivatives as active superoxide radical inhibitors

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA002396738A Division CA2396738C (en) 1990-11-30 1991-11-29 Thiazole derivatives as active superoxide radical inhibitors

Publications (2)

Publication Number Publication Date
CA2547947A1 true CA2547947A1 (en) 1992-06-25
CA2547947C CA2547947C (en) 2007-09-25

Family

ID=18311399

Family Applications (3)

Application Number Title Priority Date Filing Date
CA002547947A Expired - Lifetime CA2547947C (en) 1990-11-30 1991-11-29 Azole derivatives as active superoxide radical inhibitors
CA002396738A Expired - Lifetime CA2396738C (en) 1990-11-30 1991-11-29 Thiazole derivatives as active superoxide radical inhibitors
CA002074933A Expired - Lifetime CA2074933C (en) 1990-11-30 1991-11-29 Thiazole derivatives as active superoxide radical inhibitors

Family Applications After (2)

Application Number Title Priority Date Filing Date
CA002396738A Expired - Lifetime CA2396738C (en) 1990-11-30 1991-11-29 Thiazole derivatives as active superoxide radical inhibitors
CA002074933A Expired - Lifetime CA2074933C (en) 1990-11-30 1991-11-29 Thiazole derivatives as active superoxide radical inhibitors

Country Status (11)

Country Link
US (4) US5643932A (en)
EP (3) EP1130017B1 (en)
JP (2) JP2829451B2 (en)
KR (2) KR100195433B1 (en)
CA (3) CA2547947C (en)
DE (3) DE69132944T2 (en)
DK (3) DK0934937T3 (en)
ES (3) ES2173683T3 (en)
HK (1) HK1003938A1 (en)
TW (1) TW311136B (en)
WO (1) WO1992009586A1 (en)

Families Citing this family (96)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU657413C (en) * 1992-05-29 2007-05-03 Otsuka Pharmaceutical Co., Ltd. Thiazole derivatives for the release of superoxide radical
US5639770A (en) * 1992-05-29 1997-06-17 Otsuka Pharmaceutical Co., Ltd. Thiazole derivatives
US5565479A (en) * 1992-09-14 1996-10-15 Yamanouchi Pharmaceutical Co., Ltd. Condensed thiazole derivative, production process thereof and pharmaceutical composition thereof
AU5865794A (en) * 1993-01-19 1994-08-15 Shiseido Company Ltd. Active oxygen inhibitor composition
AU686340B2 (en) * 1994-03-11 1998-02-05 Yamanouchi Pharmaceutical Co., Ltd. 5-HT3 receptor agonist, novel thiazole derivative, and intermediate therefor
WO1996003392A1 (en) * 1994-07-27 1996-02-08 G.D. Searle & Co. Substituted thiazoles for the treatment of inflammation
DK0800519T3 (en) * 1994-12-22 2004-03-01 Ligand Pharm Inc Steroid receptor modulator compounds and methods
US5693646A (en) 1994-12-22 1997-12-02 Ligand Pharmaceuticals Incorporated Steroid receptor modulator compounds and methods
US6696459B1 (en) 1994-12-22 2004-02-24 Ligand Pharmaceuticals Inc. Steroid receptor modulator compounds and methods
JP3896552B2 (en) * 1996-03-25 2007-03-22 大塚製薬株式会社 Thiazole derivative-metal complex
WO1998008844A1 (en) * 1996-08-26 1998-03-05 Byk Gulden Lomberg Chemische Fabrik Gmbh Thiazole derivatives useful as selective inhibitors of pde-iv
EP0920426B9 (en) * 1996-08-26 2005-04-06 ALTANA Pharma AG New thiazole derivatives with phosphodiesterase-inhibiting effect
JP4300373B2 (en) * 1996-09-30 2009-07-22 大塚製薬株式会社 Cytokine production inhibitor and adhesion inhibitor
JP4305662B2 (en) * 1996-09-30 2009-07-29 大塚製薬株式会社 Cytokine production inhibitor and adhesion inhibitor
MY128323A (en) 1996-09-30 2007-01-31 Otsuka Pharma Co Ltd Thiazole derivatives for inhibition of cytokine production and of cell adhesion
JP4305668B2 (en) * 1996-09-30 2009-07-29 大塚製薬株式会社 Drug for preventing or treating diseases associated with abnormal cytokine production or increased adhesion
US6043263A (en) * 1996-11-12 2000-03-28 Byk Gulden Lomberg Chemische Fabrik Gmbh (2,3-dihydrobenzofuranyl)-thiazoles as phosphodiesterase inhibitors
AU6645998A (en) * 1996-12-23 1998-07-17 Du Pont Pharmaceuticals Company Oxygen or sulfur containing heteroaromatics as factor xa inhibitors
US6187797B1 (en) 1996-12-23 2001-02-13 Dupont Pharmaceuticals Company Phenyl-isoxazoles as factor XA Inhibitors
SI20208A (en) * 1997-06-19 2000-10-31 Dupont Pharmaceuticals Company INHIBITORS OF FACTOR Xa WITH A NEUTRAL P1 SPECIFICITY GROUP
US5998424A (en) 1997-06-19 1999-12-07 Dupont Pharmaceuticals Company Inhibitors of factor Xa with a neutral P1 specificity group
ZA985251B (en) 1997-06-19 1999-12-17 Du Pont Merck Pharma Inhibitors of factor Xa with a neutral P1 specificity group.
US6339099B1 (en) 1997-06-20 2002-01-15 Dupont Pharmaceuticals Company Guanidine mimics as factor Xa inhibitors
US5886191A (en) * 1997-08-18 1999-03-23 Dupont Pharmaceuticals Company Amidinoindoles, amidinoazoles, and analogs thereof
CA2302417A1 (en) * 1997-10-27 1999-05-06 Takeda Chemical Industries, Ltd. Adenosine a3 receptor antagonists
AU742641B2 (en) 1998-01-28 2002-01-10 Shionogi & Co., Ltd. Novel tricyclic compound
IT1300055B1 (en) * 1998-04-17 2000-04-05 Boehringer Ingelheim Italia HETEROCYCLES WITH DIPHENYL-SUBSTITUTED 5-TERM RING THEIR PREPARATION PROCEDURE AND THEIR USE AS DRUGS
US6322449B1 (en) 1998-02-04 2001-11-27 Klitsner Industrial Design, Llc Mechanical interface device
AU4394799A (en) * 1998-07-01 2000-01-24 Takeda Chemical Industries Ltd. Retinoid-associated receptor regulators
US6083966A (en) * 1998-08-31 2000-07-04 University Of Florida Thiazoline acid derivatives
CA2344913A1 (en) * 1998-09-21 2000-03-30 University Of Florida Research Foundation, Inc. Antimalarial agents
JP4336913B2 (en) * 1999-02-12 2009-09-30 大塚製薬株式会社 Method for producing amide derivative
JP2000281664A (en) * 1999-03-30 2000-10-10 Otsuka Pharmaceut Co Ltd Thiazole derivative
WO2000059902A2 (en) 1999-04-02 2000-10-12 Du Pont Pharmaceuticals Company Aryl sulfonyls as factor xa inhibitors
WO2001030757A1 (en) * 1999-10-28 2001-05-03 Microcide Pharmaceuticals, Inc. Drug discharge pump inhibitors
JP2001131151A (en) * 1999-11-02 2001-05-15 Shionogi & Co Ltd New use of olefin derivative
AU2001293847B2 (en) * 2000-10-02 2007-05-24 Janssen Pharmaceutica N.V. Metabotropic glutamate receptor antagonists
JP4160295B2 (en) * 2000-12-08 2008-10-01 武田薬品工業株式会社 Substituted thiazole derivatives having a 3-pyridyl group, method for producing the same, and use thereof
DE10102084B4 (en) 2001-01-18 2006-06-29 Wella Ag Hair colorants containing 1,4-diamino-2- (thiazol-2-yl) benzene derivatives
US7056917B2 (en) * 2001-04-26 2006-06-06 Daiichi Pharmaceutical Co., Ltd. Drug efflux pump inhibitor
WO2002087589A1 (en) * 2001-04-26 2002-11-07 Daiichi Pharmaceutical Co., Ltd. Medicine for inhibiting drug elimination pump
WO2003009844A1 (en) 2001-07-24 2003-02-06 Otsuka Pharmaceutical Co., Ltd. Use of thiazole deirvatives for the manufacture of a medicament for the treatment of chronic obstructive pulmonary disease
US8124625B2 (en) 2001-09-14 2012-02-28 Shionogi & Co., Ltd. Method of enhancing the expression of apolipoprotein AI using olefin derivatives
EP1452530A4 (en) * 2001-12-03 2005-11-30 Japan Tobacco Inc Azole compound and medicinal use thereof
FR2835254B1 (en) * 2002-01-25 2006-04-07 Sod Conseils Rech Applic THIAZOLE DERIVATIVES IN THE TREATMENT OF NEUROLOGICAL DISEASES
US6822097B1 (en) * 2002-02-07 2004-11-23 Amgen, Inc. Compounds and methods of uses
PE20030968A1 (en) 2002-02-28 2004-01-12 Novartis Ag DERIVATIVES OF 5-PHENYLTIAZOLE AS KINASE INHIBITORS
CA2483771A1 (en) * 2002-04-30 2004-03-25 Merck & Co., Inc. Aryl-link-aryl substituted thiazolidine-dione and oxazolidine-dione as sodium channel blockers
AU2003224335A1 (en) * 2002-05-15 2003-12-02 Smithkline Beecham Corporation Benzoxazine and benzoxazinone substituted triazoles
WO2004017959A2 (en) * 2002-08-22 2004-03-04 University Of Florida Antioxidant and radical scavenging activity of synthetic analogs of desferrithiocin
US20040044220A1 (en) * 2002-08-22 2004-03-04 University Of Florida Antioxidant and radical scavenging activity of synthetic analogs of desferrithiocin
DE20301728U1 (en) 2002-10-11 2004-03-11 Ligand Pharmaceuticals, Inc., San Diego 5-substituted-7,9-difluoro-5H-chromeno (3,4-f) quinoline compounds as selective progesterone receptor modulator compounds
US20040147561A1 (en) * 2002-12-27 2004-07-29 Wenge Zhong Pyrid-2-one derivatives and methods of use
MXPA05010945A (en) * 2003-04-09 2005-11-25 Japan Tobacco Inc Heteroaromatic pentacyclic compound and medicinal use thereof.
TW200503700A (en) * 2003-07-17 2005-02-01 Otsuka Pharma Co Ltd Enema preparation
WO2005034949A1 (en) * 2003-09-09 2005-04-21 University Of Florida Desferrithiocin derivatives and their use as iron chelators
CN1946703A (en) * 2004-04-20 2007-04-11 特兰斯泰克制药公司 Substituted thiazole and pyrimidine derivatives as melanocortin receptor modulators
AU2005243384A1 (en) * 2004-05-17 2005-11-24 Otsuka Pharmaceutical Co., Ltd. Thiazole compound and use thereof
MX2007012226A (en) 2005-04-04 2007-12-10 Univ Florida Desferrithiocin polyether analogues.
EP1932833B1 (en) * 2005-10-07 2012-08-01 Kissei Pharmaceutical Co., Ltd. Nitrogenated heterocyclic compound and pharmaceutical composition comprising the same
WO2007077961A2 (en) * 2005-12-28 2007-07-12 Takeda Pharmaceutical Company Limited Fused heterocyclic compounds and their use as mineralocorticoid receptor ligands
TWI394753B (en) * 2006-03-17 2013-05-01 Otsuka Pharma Co Ltd Novel tetomilast crystal
TW200815054A (en) 2006-06-19 2008-04-01 Otsuka Pharma Co Ltd Methods of using a thiazole derivative
DK2363130T3 (en) 2006-07-05 2014-07-21 Takeda Gmbh Combination of HMG-CoA reductase inhibitors atorvastatin or simvastatin with a phosphodiesterase 4 inhibitor such as roflumilast for the treatment of inflammatory pulmonary diseases
TW200815428A (en) 2006-08-15 2008-04-01 Wyeth Corp Oxazolidone derivatives as PR modulators
US7618989B2 (en) 2006-08-15 2009-11-17 Wyeth Tricyclic oxazolidone derivatives useful as PR modulators
US7538107B2 (en) 2006-08-15 2009-05-26 Wyeth Oxazinan-2-one derivatives useful as PR modulators
US7649007B2 (en) 2006-08-15 2010-01-19 Wyeth Llc Oxazolidine derivatives as PR modulators
WO2008021309A1 (en) 2006-08-15 2008-02-21 Wyeth Imidazolidin-2-one derivatives useful as pr modulators
US9233941B2 (en) 2007-02-02 2016-01-12 Baylor College Of Medicine Methods and compositions for the treatment of body weight related disorders
US9212179B2 (en) 2007-02-02 2015-12-15 Baylor College Of Medicine Compositions and methods for the treatment of metabolic disorders
US9085566B2 (en) 2007-02-02 2015-07-21 Baylor College Of Medicine Compositions and methods for the treatment of metabolic and related disorders
CA2677264C (en) 2007-02-02 2021-11-30 Baylor College Of Medicine Compositions and methods for the treatment of metabolic disorders
US9187485B2 (en) 2007-02-02 2015-11-17 Baylor College Of Medicine Methods and compositions for the treatment of cancer and related hyperproliferative disorders
WO2008115433A1 (en) 2007-03-15 2008-09-25 University Of Florida Desferrithiocin polyether analogues
HUE036086T2 (en) 2007-08-13 2018-06-28 Monsanto Technology Llc Compositions and methods for controlling nematodes
CA2736177A1 (en) * 2007-09-06 2009-03-12 Boston Biomedical, Inc. Compositions of kinase inhibitors and their use for treatment of cancer and other diseases related to kinases
US8822513B2 (en) 2010-03-01 2014-09-02 Gtx, Inc. Compounds for treatment of cancer
US9447049B2 (en) 2010-03-01 2016-09-20 University Of Tennessee Research Foundation Compounds for treatment of cancer
US9029408B2 (en) 2008-06-16 2015-05-12 Gtx, Inc. Compounds for treatment of cancer
TR201903981T4 (en) * 2008-06-16 2019-04-22 Univ Ohio State Res Found Compounds for cancer treatment.
WO2010025142A1 (en) * 2008-08-29 2010-03-04 Transtech Pharma, Inc. Substituted aminothiazole derivatives, pharmaceutical compositions, and methods of use
ES2590904T3 (en) 2008-10-17 2016-11-24 Akaal Pharma Pty Ltd Modulators of S1P receptors and their use
EP2344446A4 (en) 2008-10-17 2012-04-04 Akaal Pharma Pty Ltd S1p receptors modulators
EP2542081A4 (en) 2010-03-01 2013-07-31 Gtx Inc Compounds for treatment of cancer
PT2718290T (en) * 2011-06-07 2016-07-14 Clevexel Pharma Compositions and methods for modulating a kinase
WO2012170371A1 (en) * 2011-06-10 2012-12-13 N30 Pharmaceuticals, Llc Compounds as s-nitrosoglutathione reductase inhibitors
KR102111176B1 (en) 2011-12-16 2020-05-15 유니버시티 오브 플로리다 리서치 파운데이션, 인코포레이티드 Uses of 4'-desferrithiocin analogs
ES2609459T3 (en) * 2012-08-23 2017-04-20 The Institute Of Cancer Research : The Royal Cancer Hospital Condensed heterocyclic compounds and their use
US9701638B2 (en) * 2012-11-09 2017-07-11 Rutgers, The State University Of New Jersey Therapeutic hydroxyquinolones
JP6835472B2 (en) 2013-03-05 2021-02-24 ユニバーシティ オブ テネシー リサーチ ファウンデーション Compositions for the treatment of cancer
US9408796B2 (en) 2013-03-13 2016-08-09 Avon Products, Inc Cosmetic compositions for improving the appearance of skin
EP3039022A4 (en) * 2013-08-29 2017-08-16 Baylor College Of Medicine Compositions and methods for the treatment of metabolic and body weight related disorders
WO2015077655A1 (en) 2013-11-22 2015-05-28 University Of Florida Research Foundation, Inc. Desferrithiocin analogs and uses thereof
SG11201705013QA (en) 2014-12-19 2017-07-28 Galderma Res & Dev Novel compounds, synthesis method thereof and use of same in medicine and in cosmetics
EP3288557A4 (en) 2015-04-27 2018-11-07 University of Florida Research Foundation, Inc. Metabolically programmed metal chelators and uses thereof

Family Cites Families (85)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1970656A (en) * 1931-11-04 1934-08-21 Winthrop Chem Co Inc Thiazole compound and process of producing the same
NL284415A (en) * 1961-10-19
JPS3910130B1 (en) * 1962-05-10 1964-06-10
US3320270A (en) * 1963-10-08 1967-05-16 Tri Kem Corp Certain 2-acylimidothiazole compounds
US3401120A (en) * 1965-10-23 1968-09-10 Gaf Corp Corrosion inhibitors
GB1139940A (en) * 1966-09-30 1969-01-15 Ici Ltd Oxazole derivatives
DE1670383A1 (en) * 1966-09-14 1970-10-29 Ciba Geigy Novel tetrahydroimidazoles and processes for their preparation
US3462448A (en) * 1966-10-27 1969-08-19 Dow Chemical Co Substituted phenyl thiazole compounds
IL28803A (en) * 1966-11-18 1974-05-16 Wyeth John & Brother Ltd Oxazole and thiazole compounds,their preparation and pharmaceutical compositions containing them
GB1226548A (en) * 1967-06-14 1971-03-31 Wyeth John & Brother Ltd
GB1245087A (en) * 1967-10-26 1971-09-02 Wyeth John & Brother Ltd Heterocyclic compounds
US3625999A (en) * 1968-02-19 1971-12-07 Lever Brothers Ltd Process for the preparation of phosphonium sulfonate salts
FR96117E (en) * 1968-03-28 1972-05-19 Aquitaine Petrole Synthesis of oxazoles.
CY800A (en) * 1968-04-09 1976-12-01 Wyeth John & Brother Ltd Novel thiazoline derivatives, the preparation thereof and compositions containing the same
US4001420A (en) * 1968-12-12 1977-01-04 Science Union Et Cie, Societe Francaise De Recherche Medical Thiazolyl benzoic acid compounds
GB1248070A (en) * 1968-12-16 1971-09-29 Science Union & Cie Thiazolyl-benzoic acid derivatives and process for preparing them
US3635999A (en) 1969-03-25 1972-01-18 Aquitaine Petrole Synthesis of oxazoles
JPS4637822B1 (en) * 1969-05-31 1971-11-08
US3705153A (en) * 1969-05-14 1972-12-05 Sumitomo Chemical Co Novel thiazolyacetic acids and salts thereof
JPS4624696B1 (en) * 1969-06-30 1971-07-15
FR2082164A5 (en) * 1970-03-05 1971-12-10 Aries Robert Phenylalkyl esters of oxazolyl and thiazolyl carboxylic - acids - analgesics, antiinflammatories, tranquilisers
GB1308028A (en) * 1970-06-12 1973-02-21 Science Union & Cie Thiazolylbenzoic acid derivatives and a process for their manufactur
DE2048272C3 (en) * 1970-10-01 1974-10-17 Dynamit Nobel Ag, 5210 Troisdorf Process for the preparation of 1,1,2-trimethoxyethane and o-acetic acid methyl ester
CA962269A (en) 1971-05-05 1975-02-04 Robert E. Grahame (Jr.) Thiazoles, and their use as insecticides
GB1381860A (en) * 1971-06-03 1975-01-29 Wyeth John & Brother Ltd Tetrazole derivatives
JPS471469A (en) * 1971-06-22 1972-01-25
DE2152367C2 (en) * 1971-10-21 1985-01-03 Basf Ag, 6700 Ludwigshafen Process for the preparation of 4-methyl-oxazoles
BE791087A (en) * 1971-11-15 1973-03-01 Lepetit Spa 2,4,5-TRISUBSTITU OXAZOLES AND THEIR PREPARATION
BE794096A (en) * 1972-08-07 1973-05-16 Lepetit Spa 2,4,5-TRISUBSTITU OXAZOLES AND THEIR PREPARATION
JPS4938268A (en) * 1972-08-16 1974-04-09
JPS4938267A (en) * 1972-08-18 1974-04-09
JPS5327586B2 (en) * 1972-08-23 1978-08-09
JPS503315A (en) * 1973-05-10 1975-01-14
US4072689A (en) * 1973-02-22 1978-02-07 Gruppo Lepetit S.P.A. Monoamino 2,4,5-trisubstituted oxazoles
JPS5030619A (en) * 1973-07-23 1975-03-26
HU168036B (en) * 1973-11-09 1976-02-28
DE2711655A1 (en) * 1977-03-17 1978-09-21 Basf Ag PYRIDINYL-AMINOALKYLAETHER
US4259341A (en) * 1977-06-01 1981-03-31 Merck & Co., Inc. Di- and tri-substituted thiazoles
US4153703A (en) * 1977-06-30 1979-05-08 Uniroyal, Inc. Method of controlling insects and acarids with certain aryl-substituted thiazoles
JPS5461936A (en) * 1977-10-26 1979-05-18 Ricoh Co Ltd Photoreceptor for electrophotography
JPS6051475B2 (en) * 1977-11-08 1985-11-14 久光製薬株式会社 Novel phenyl acetic acid derivative
GB1574583A (en) * 1978-02-09 1980-09-10 Wyeth John & Brother Ltd Process for preparing thiazoles
US4218458A (en) * 1978-06-23 1980-08-19 Janssen Pharmaceutica, N.V. Heterocyclic derivatives of (4-aryloxy-methyl-1,3-dioxolan-2-yl)methyl-1H-imidazoles and 1H-1,2,4-triazoles
US4221584A (en) * 1979-02-09 1980-09-09 Chevron Research Company Herbicidal and plant-growth-regulating N-(heterocyclyl)-methylacetanilides
JPS55111418A (en) * 1979-02-21 1980-08-28 Santen Pharmaceut Co Ltd Remedy for eye disease and its preparation
NZ193011A (en) * 1979-03-19 1983-03-15 Ici Australia Ltd Diarylamine derivatives intermediates herbicidal compositions
AU534093B2 (en) * 1979-03-19 1984-01-05 Ici Australia Limited Thiazoles,benzthiazoles, benzoxazoles and benzimidazoles
JPS55133366A (en) * 1979-04-05 1980-10-17 Otsuka Pharmaceut Factory Inc Thiazole derivative
US4298743A (en) * 1979-09-11 1981-11-03 Merck & Co., Inc. 4-(Substituted phenyl thiazolyl)-3-hydroxy-3-pyrroline-2,5-diones
JPS56123544A (en) * 1980-03-03 1981-09-28 Hitachi Ltd Composite type electrophotographic plate and electrophotographic method using it
US4322428A (en) * 1980-04-02 1982-03-30 Eli Lilly And Company 2(4-Fluorophenyl)-4,5,-bis(4-methoxyphenyl)thiazole and method of use
ZA811691B (en) * 1980-04-03 1982-10-27 Wyeth John & Brother Ltd Thiazoles
US4329459A (en) * 1980-05-05 1982-05-11 The Upjohn Company Tetrahydrobenzopyran derivatives
US4282364A (en) * 1980-05-22 1981-08-04 Merck & Co., Inc. Process for the preparation of thiazoles
JPS58120257A (en) * 1982-01-12 1983-07-18 Hitachi Chem Co Ltd Electrophotographic receptor
DD204094A1 (en) * 1982-02-11 1983-11-16 Horst Hartmann PROCESS FOR PREPARING 2-ARYL-4-CUMARYL- (3 ') - BZW. 2,4-BIS-coumaryl (3 ') - thiazoles
JPS58201771A (en) * 1982-05-19 1983-11-24 Tanabe Seiyaku Co Ltd Alkyloxazolylacetic acid derivative and its preparation
JPS58219169A (en) * 1982-06-15 1983-12-20 Takeda Chem Ind Ltd Oxazoleacetic acid derivative
JPS5925381A (en) * 1982-06-30 1984-02-09 Hisamitsu Pharmaceut Co Inc Novel phenylacetic acid derivative
JPS5925380A (en) * 1982-06-30 1984-02-09 Hisamitsu Pharmaceut Co Inc Novel phenylacetic acid derivative
US4659657A (en) * 1982-12-24 1987-04-21 Bayer Aktiengesellschaft Chromogenic and fluorogenic esters for photometric or fluorimetric determination of phosphatases or sulphatases
JPS6058981A (en) * 1983-09-09 1985-04-05 Takeda Chem Ind Ltd 5-pyridyl-1,3-thiazole derivative, production thereof and medicinal composition containing the same
JPS6051111A (en) * 1983-08-30 1985-03-22 Tanabe Seiyaku Co Ltd Cholesterol-lowering agent
JPS60151045A (en) * 1984-01-19 1985-08-08 富士写真フイルム株式会社 Packaging material for photosensitive material
DE3406329A1 (en) * 1984-02-22 1985-08-22 Merck Patent Gmbh, 6100 Darmstadt PYRIDONE
JPS6133186A (en) * 1984-07-25 1986-02-17 Kanebo Ltd Novel diphehylpyrrolylthiazole derivative, its preparation and pharmaceutical composition containing said derivative as active component
JPS60222481A (en) * 1984-04-19 1985-11-07 Kanebo Ltd Novel diphenylpyrrolylthiazole derivative, its preparation, and drug composition comprising it as active ingredient
US4659726A (en) * 1984-04-19 1987-04-21 Kanebo, Ltd. Novel 4,5-Bis (4-methoxyphenyl)-2-(pyrrol-2-yl) thiazoles and pharmaceutical composition containing the same
JPS61200985A (en) * 1985-02-28 1986-09-05 Kanebo Ltd Novel diphenylpyrrolylthiazole derivative, production thereof, and drug composition comprising same as active ingredient
JPS60230147A (en) * 1984-04-27 1985-11-15 Ricoh Co Ltd Original printing plate for electrophotoengraving
DE3425118A1 (en) * 1984-07-07 1986-01-16 Boehringer Mannheim Gmbh, 6800 Mannheim NEW REDOX INDICATORS
JPS6123790A (en) * 1984-07-12 1986-02-01 Hitachi Cable Ltd Method for plating ni or ni alloy surface
DE3501696A1 (en) * 1985-01-19 1986-07-24 Bayer Ag, 5090 Leverkusen PYRIDOPYRIMIDINE, SEVERAL PROCESS FOR THEIR PRODUCTION AND THEIR USE AS MEDICINAL PRODUCT
DE3525689C1 (en) * 1985-07-18 1986-10-30 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Method and device for operating a dye laser working with a proton transfer reaction
CA1292226C (en) * 1986-01-16 1991-11-19 Terumi Hachiya Indenothiazole derivative and process for preparing the same
DE3601411A1 (en) * 1986-01-20 1987-07-23 Nattermann A & Cie 3-Amino-1-(2-thiazolyl)-2-pyrazolines, process for their preparation and pharmaceutical preparations containing these
KR900000566B1 (en) * 1986-04-30 1990-01-31 에프 엠 씨 코포레이션 Photoactive azole pesticides
JPH075579B2 (en) * 1986-09-01 1995-01-25 吉富製薬株式会社 Aminothiazole compound
JPS63192755A (en) * 1987-02-06 1988-08-10 Fujisawa Pharmaceut Co Ltd 2-phenylazole derivative and salt thereof
US4791200A (en) * 1987-06-22 1988-12-13 Ortho Pharmaceutical Corporation 2-substituted-4-aryl-substituted thiazoles
JPS6422861A (en) * 1987-07-18 1989-01-25 Kirin Brewery New substance ag55-2
MY104933A (en) * 1987-09-30 1994-07-30 Pfizer Ltd Platelet activating factor antagonists
JPH02171280A (en) * 1988-12-26 1990-07-02 Agency Of Ind Science & Technol Fluorescent ink composition for ink jet
DE3929233A1 (en) 1989-09-02 1991-03-07 Bayer Ag New heterocyclyl:pyridine-benzyl:amide and anilide cpds. - useful herbicides from e.g. amino:alkenoic acids and ketone(s) followed by oxidation
AU621245B2 (en) * 1989-10-17 1992-03-05 Boehringer Mannheim Gmbh Hydrolase substrates, a process for the preparation thereof and agents containing them

Also Published As

Publication number Publication date
DE69132944T2 (en) 2002-11-21
EP0934937B1 (en) 2002-02-27
HK1003938A1 (en) 1998-11-13
USRE37556E1 (en) 2002-02-19
DE69132006T2 (en) 2000-08-03
ES2173683T3 (en) 2002-10-16
EP0513387A1 (en) 1992-11-19
DK0513387T3 (en) 2000-06-05
DK0934937T3 (en) 2002-04-02
EP0934937A1 (en) 1999-08-11
CA2547947C (en) 2007-09-25
EP1130017A3 (en) 2001-09-19
CA2074933A1 (en) 1992-05-31
JP2829451B2 (en) 1998-11-25
EP0513387A4 (en) 1993-04-21
DE69133471T2 (en) 2006-05-11
ES2144403T3 (en) 2000-06-16
DK1130017T3 (en) 2005-10-10
US5677319A (en) 1997-10-14
AU8936791A (en) 1992-06-25
WO1992009586A1 (en) 1992-06-11
KR100249545B1 (en) 2000-04-01
DE69132006D1 (en) 2000-04-06
ES2245660T3 (en) 2006-01-16
CA2074933C (en) 2002-12-03
CA2396738A1 (en) 1992-06-25
AU656930B2 (en) 1995-02-23
US5643932A (en) 1997-07-01
DE69132944D1 (en) 2002-04-04
EP0513387B1 (en) 2000-03-01
TW311136B (en) 1997-07-21
KR100195433B1 (en) 1999-06-15
JPH0551318A (en) 1993-03-02
DE69133471D1 (en) 2005-07-21
JP3182556B2 (en) 2001-07-03
EP1130017B1 (en) 2005-06-15
EP1130017A2 (en) 2001-09-05
JPH10101562A (en) 1998-04-21
KR927003551A (en) 1992-12-18
CA2396738C (en) 2006-08-29
US6080764A (en) 2000-06-27

Similar Documents

Publication Publication Date Title
CA2547947A1 (en) Azole derivatives as active superoxide radical inhibitors
AU1200695A (en) 4,5-diaryloxazole derivatives
EP1288199A4 (en) Mmp-12 inhibitors
AU7186494A (en) Substituted spiroheterocyclic 1h-3-arylpyrrolidine-2,4-dione derivatives, methods of preparing them and their use as pest-control agents
WO2001077107A8 (en) Oxazole derivatives and their uses as tyrosine kinase inhibitors
CA2165819A1 (en) Dc-89 derivatives
CA2043071A1 (en) Heterocyclic compounds
CA2319005A1 (en) 2-pyridylmethylamine derivatives useful as fungicides
CA2301093A1 (en) Fluoropyrazole-biphenylamide fungicides
MX9800577A (en) 4,5-diaryl oxazole derivatives.
MY118612A (en) Pyrazine compounds
CA2359646A1 (en) Complex of ras-farnesyltransferase inhibitor and sulfobutylether-7-.beta.-cyclodextrin or 2-hydroxypropyl-.beta.-cyclodextrin and method
DK1044967T3 (en) 2-pyridinylguanidine urokinase inhibitor
EP0908453A4 (en)
MY128323A (en) Thiazole derivatives for inhibition of cytokine production and of cell adhesion
AU5504694A (en) Substituted amic acid derivatives
WO2002028844A1 (en) Thiazole or oxazole derivatives
ZA91923B (en) Indole derivatives
CA2309474A1 (en) New 4-arylpiperidine derivatives for the treatment of pruritus
DE69122812T2 (en) GLUTATHION DERIVATIVE
TW350838B (en) Quinoline derivatives
HU9203849D0 (en) Thiazole derivatives
AU623500B2 (en) Carboxylimino benzothiazole derivatives
EP0516860A4 (en) Chromone derivative and aldose reductase inhibitor containing the same as active ingredient
EP0721930A4 (en) Benzoylethylene derivative

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry